Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

Mostrar otras versiones (1)

Breast cancer (BC) patients with a germline CHEK2 c.1100delC variant have an increased risk of contralateral BC (CBC) and worse BC-specific survival (BCSS) compared to non-carriers. We aimed to assess the associations of CHEK2 c.1100delC, radiotherapy, and systemic treatment with CBC risk and BCSS....

Descripción completa

Detalles Bibliográficos
Autores principales: Morra, Anna, Schreurs, Maartje A. C., Andrulis, Irene L., Anton-Culver, Hoda, Augustinsson, Annelie, Beckmann, Matthias W., Behrens, Sabine, Bojesen, Stig E., Bolla, Manjeet K., Brauch, Hiltrud, Broeks, Annegien, Buys, Saundra S., Camp, Nicola J., Castelao, Jose E., Cessna, Melissa H., Chang-Claude, Jenny, Chung, Wendy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949248/
https://www.ncbi.nlm.nih.gov/pubmed/36824750
http://dx.doi.org/10.21203/rs.3.rs-2569372/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949248/
https://www.ncbi.nlm.nih.gov/pubmed/36824750
http://dx.doi.org/10.21203/rs.3.rs-2569372/v1

Ejemplares similares